Description

Updated: This adoption modifies the Annual Statement Line numbers (ASL) to include additional breakouts of certain lines to ensure consitency across schedules and to change the Health ASL categories to match the lines of business (LOB) categories used in the Health and Life/Fraternal statements.

Effective 1st Quarter 2022

References: 2020-33BWG Modified

Updated:This adoption expands the number of characters used from seven to ten in the investment line categories for the schedules listed. It adds line categories for Unaffiliated Certificates of Deposit and Exchange Traded Funds. It will split the line categories for Mutual Funds, Investment Unit Trusts and Closed-End Funds into lines indicating if the fund has been assigned a designation by the SVO or not. Changes will be made to the Summary Investment Schedule, Summary by Country and Sch D, Part 1A (Sections 1 and 2) to reflect the additional line categories. The purpose of the proposal is to change the line number size to accommodate more line categories and to allow for room in the numbering scheme for Schedules D, DA, DL and E to add additional lines in the future without major distruption of line numbering. It also adds new lines to address crosscheck issues and reporting questions that have been received in the past.

Effective 1st Quarter, 2022

References:2020-35BWG Modified

Updated: This adoption removes language from General Interrogatories, Part 1, Line 4.1 regarding the requirement of filing a quarterly merger/history form

Effective 1st Quarter, 2022

References: 2021-10BWG

Updated: This adoption expands the the lines of business reported on Schedule H for Life and Property to match the lines of business reported on the Health Statement.

Effective Annual 2022

References: 2021-14BWG Modified

Updated: This item adds a footnote to Exhibit 7 in the Life/Fraternal Statement and the Health Statement (Life Supplement) to capture the amount of FHLB Funding Agreements reported in Columns 1 through 6 of the exhibit. The adoption coincides with the SAPWG adoption of AP&P Ref #2021-16.

Effective Annual 2022

References: 2021-15BWG, AP&P Ref #2021-16

Updated: This item adds columns and lines to U&I Parts 1, 2, 2A, 2B and 2D and to the Exhibit of Premiums, Enrollment and Utilization in the Annual Statement to bring the lines of business reporting in sync with Life/Fraternal and Property. Lines and columns will also be added to the 2023 Quarterly Exhibit of Premiums, Enrollment and Utilization and the U&I Analysis of Claims Unpaid. The instructions will be updated to reflect these changes.

Effective Annual 2022

References: 2021-19BWG Modified

Updated: This item concides with the SAPWG adoption of AP&P Ref #2021-15. The Investment Schedules General Instructions were modified to exclude residual tranches or interests from being reported as bonds on Schedule D and adds lines to Schedule BA for the reporting of those investments.

Effective Annual 2022

References: 2021-21BWG Modified, AP&P Ref #2021-15

Updated: This item adds electronic columns to the investment schedules to capture information regarding investment transactions with related parties. In addition to capturing direct loans in related parties, it will also capture information involving securitizations (or other similar investments) where the related party is a sponsor/originator along with whether the underlying investment is in a related party. This information will be captured regardless if the specific affiliate definition has been met or if there has been a disclaimer of affiliation/control.

Effective Annual 2022

References: 2021-22BWG Modified

New: This item adds new reportling lines for Residual Tranches or Interests to the AVR Equity and Other Invested Asset Component blank (and renumbers the lines below).

Effective Annual 2022

References: 2021-23BWG Modified

Updated: This item adds new questions to the Investment section of General Interrogatories, Part 1 on whether the reporting entity accepts cryptocurrency for payment of premiums, which cryptocurrencies are accepted and whether they are held for investment or immediately converted to U.S. dollars. Questions 38.1, 38.2, 39.2, 39.21, 39.22 and 39.3 will be added, forcing the subsequent questions in the “Other” section of the interrogatories to be renumbered. This BWG item is associated with the SAPWG adoption of AP&P Ref #2021-24.

Effective Annual 2022

References: 2022-01BWG, AP&P Ref #2021-24

Updated: This item adds four new electric only columns to Schedule D, Part 6, Section 1 for Prior Year Book/Adjusted Carrying Value (Column 16), Prior Year Nonadmitted Amount (Column 17), Prior Year Sub-2 Verified Value (Column 18) and Prior Year VISION filing number (Column 19). This BWG item is associated with the SAPWG adoption of AP&P Ref #2021-22.

Effective Annual 2022

References: 2022-02BWG Modified, AP&P Ref #2021-22

New: This item adds clarifying line numbers to the active status data points in the Schedule T footnote.

Effective Annual 2022

References: 2022-05BWG Modified

Updated: This item amends the Health Annual Statement Test language in the Annual Statement Instructions.

Effective Annual 2022

References: 2022-06BWG Modified

New: This item modifies the language in sections 1A, 4, 5, 7 and 9 of the Health blank Annual Statement instructions related to the actuarial opinion to ensure that all items (actuarial assets and liabilities) within the scope of the statement of actuarial opinion are treated consistently.

Effective Annual 2022

References: 2022-07BWG

Updated: This item modifies the guidance in sections 1, 3 and 8 of the Property blank Annual Statement instructions related to the actuarial opinion.

Effective Annual 2022

References: 2022-08BWG

Updated: This item modifies the VM-20 Reserves Supplement, Part 2. Question 3 will be added to allow disclosure of the year the Life PBR Exemption was actively filed and a confirmation of the eligibility criteria in the case of ongoing exemptions. In addition, this item will correct references to a state “granting” an exemption, since this is often not the case (e.g., the exemption may be allowed). The Supplemental Exhibits and Schedules Interrogatories on the Quarterly statement will be modified to add instructions for how to respond to Question 8 if the company is utilizing the ongoing exemption.

Effective Annual 2022

References: 2022-09BWG

Updated: This item coincides with SAPWG AP&P Ref #2022-03. The instructions have been updated for Schedule T, State pages and A&H Policy Experience Exhibit to clarify guidance for reporting premium adjustments by jurisdiction.

Effective Annual 2022

References: 2022-10BWG, AP&P Ref #2022-03

Updated: This item updates the AVR factors to be consistent with the RBC factors for the expanded bond designation categories that were implemented in the Life RBC for 2021 year-end reporting. The AVR maximum reserve factors were updated to reflect the existing relationship to the RBC after-tax factors. The AVR basic contribution and reserve objective factors were updated to reflect the existing relationships to the maximum reserve factors.

Effective Annual 2022

References: 2022-11BWG Modified

Updated: This item modifies the Five-Year Historical Data questions 68 and 69 to reference group comprehensive and modifies questions 70 and 71 to reflect inclusion of all health lines of business other than group comprehensive. Crosschecks for these questions will be modified accordingly. The changes coincide with the changes to the lines of business captured on Schedule H.

Effective Annual 2022

References: 2022-13BWG Modified